Mobile site search icon.
Mobile navigation icon.

TAKHZYRO (lanadelumab-flyo) is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients ≥2 years of age.

TAKHZYRO (lanadelumab-flyo) is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients ≥2 years of age.

OnePath® Product
Support for Patients

Through OnePath, patients are connected with a dedicated Patient Support Manager who can assist them with:

Facilitating insurance benefits investigation to verify coverage
Working with specialty pharmacies to facilitate treatment access
Getting patients and/or caregivers started successfully with self-administration training,
led by a specially trained nurse
Providing information about financial assistance options
Informing patients and caregivers about educational resources available to them

Patients enrolled in OnePath may use the OnePath Mobile App to connect with OnePath and track their health in a personal eDiary.

To enroll in OnePath, follow these 4 simple steps.

OnePath Co-pay Assistance Program

Patients 12 years of age and older with commercial insurance may be eligible for the OnePath Co-pay Assistance Program.

This program will help cover the cost of insurance co-pays for TAKHZYRO at 100% for eligible patients, up to the program maximum.

There are no financial requirements or waiting periods to participate in this program.

IMPORTANT NOTICE: The OnePath Copay Assistance Program (the Program) is not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), Tricare, Medigap, VA, DoD, or other federal or state programs (including any medical or state prescription drug assistance programs). No claim for reimbursement of the out-of-pocket expense amount covered by the Program shall be submitted to any third party payer, whether public or private. The Program cannot be combined with any other rebate/coupon, free trial, or similar offer. Copayment assistance under the Program is not transferable. The Program only applies in the United States, including Puerto Rico and other U.S. territories, and does not apply where prohibited by law, taxed, or restricted. This does not constitute health insurance. Void where use is prohibited by your insurance provider. If your insurance situation changes you must notify the Program immediately at 1-866-888-0660. Coverage of certain administration charges will not apply for patients residing in states where it is prohibited by law. Takeda reserves the right to rescind, revoke, or amend the Program at any time without notice.

To enroll in OnePath, complete this start form with your patient and fax it to 1-855–ONEPATH (1-855-663-7284).

Download start form

Please see complete Important Safety Information below and full Prescribing Information